Astia Angels and Wheatsheaf Group have backed the genomic analytics firm in its latest funding round.
"We have developed innovative analytics and AI capabilities that enable a new generation of precision medicine and precision agriculture solutions. The ability to deliver combinatorial, multi-omic analysis at scale is a critical missing piece in realising the benefits of the genomics, IOT and AI revolutions. This investment will enable us to scale our business to address the significant global opportunities in these high-growth markets."
The doctor-on-demand application closed the crowd and angel raise at a post-money valuation of £5.2m.
"We’re delighted to welcome Dr Sandeep, Hiten and Yann to our growing team at Qured at such an exciting time in the company’s journey. From initially just covering Clapham to now providing our service to South West London and Zones 1 and 2 in just over six months is both fulfilling and exciting. It reinforces our belief that there is a heightened demand for an affordable and convenient healthcare service which works around people’s lives, offering easier, quicker and hassle-free access to primary healthcare."
The funding was led by Startup Funding Club and the London Co-Investment Fund to support insurance solutions for the sharing economy.
"There is currently a gap in the provision of insurance products tailored for the needs of the sharing economy and we believe that Tapoly have designed solutions that are highly innovative and value adding for the sector. We are pleased to back a very credible management team and to be co-investing with the London Co-investment Fund on their 100th investment!"
The theatre app surpassed its £200k target with backing from its community of users.
"This is a very exciting time for our company and I would like to thank all our investors for sharing our vision. Together, we will continue to make theatre more accessible and help introduce new audiences to our fantastic industry."
.png)
